Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries.

PRODUCTS & SERVICES

Tempus ALS® is an advanced solution to manage out-of-hospital emergency, build over a modular solution including multi-parametric monitor/defibrillation equipment that provides better care in the emergency environment and rescue units. The combined solution brings together the vital signs monitor together with a small-sized biphasic defibrillator that, together with the equipment's data transmission capacity to Intellispace Corsium platform, as a remote care consultation tool, adds a real Telemedicine solution to the equipment, creating the Tempus ALS advanced life support system.